MoonLake Immunotherapeutics
MLTX • NASDAQ
MoonLake Immunotherapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jorge Santos da Silva, with a market cap of $1.3B.
CEOJorge Santos da Silva
Next Earnings
Upcoming earnings announcement for MoonLake Immunotherapeutics
Date
Monday, May 11, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.92
Earnings History
Past 12 earnings reports for MoonLake Immunotherapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 25, 2026 | Q4 2025 | -$0.92Est: -$0.99 | +7.1% | - | — |  10-K |
| Nov 5, 2025 | Q3 2025 | -$1.10Est: -$0.91 | -20.9% | - | — | 10-Q |
| Aug 5, 2025 | Q2 2025 | -$0.87Est: -$0.75 | -16.0% | - | — | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.63Est: -$0.75 | +16.0% | - | — | 10-Q |
| Feb 26, 2025 | Q4 2024 | -$0.72Est: -$0.62 | -16.1% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.56Est: -$0.44 | -27.3% | - | — | 10-Q |
| Aug 7, 2024 | Q2 2024 | -$0.39Est: -$0.28 | -39.3% | - | — | 10-Q |
| May 7, 2024 | Q1 2024 | -$0.22Est: -$0.20 | -10.0% | - | — | 10-Q |
| Feb 29, 2024 | Q4 2023 | -$0.10Est: -$0.23 | +56.5% | - | — | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.18Est: -$0.23 | +21.7% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.23Est: -$0.26 | +11.5% | - | — | — |
| May 12, 2023 | Q1 2023 | -$0.23 | — | - | — | — |